Molecular monitoring of falciparaum malaria isolates in Côte d'Ivoire: Genetic markers (dhfr-ts, dhps, pfcrt, pfmdr-1) for antimalarial-drugs resistance

European Journal of Scientific Research

Volumn 40, Issue 3, 2010, Pages 461-470

  Djaman, Joseph ^a   Ahibo, Hugues ^b   Yapi, Félix Houphouët ^b   Bla, Brice Kouakou ^b   Ouattara, Lacina ^b   Yavo, William ^b   N'guessan, Jean David ^b   Yapo, Adou ^b   Mazabraud, André ^a  

^a Institut Pasteur de Côte d'Ivoire Université de Cocody Côte d'Ivoire   (France)

^b UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

Author keywords

C te d'Ivoire; Molecular markers; Plasmodium falciparum

Indexed keywords

EID: 78651441711     PISSN: 1450216X     EISSN: 1450202X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Basco, L.K and Ringwald P., 2000. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparumdihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am. J. Trop. Med. Hyg., 62, 271-276. (Pubitemid 30257589)
2. Basco, L.K., Eldin de Pecoulas, P., Wilson, C. M., Le Bras, J., Mazabraud, A. 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol. Biochem. Parasitol., 69, 135-138.
3. Bridges, D.J, Molyneux, M, Nkhoma S., 2009. Low level genotypic chloroquine resistance near Malawi's northern border with Tanzania, Trop. Med. Int. Health. 14, 1093-1096.
4. Djaman, J.A., Bla, B.K., Yavo, W., Yapi, H.F., Mazabraud, A., Basco, L.K. 2007. Polymorphism of Pfcrt and Pfmdr-1 Genes of Plasmodium falciparum and chloroquine Susceptibility in Côte d'Ivoire. Acta. Protozool. 46, 361-365.
5. Djimde, A.A., Fofana, B., Sagara, I., Sidibe, B., Toure, S., Dembele, D., Dama, S., Ouologuem, D., Dicko, A., Doumbo, O. K. 2008. Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in Mali. Am. J. Trop. Med. Hyg. 78, 455-461. (Pubitemid 351845197)
6. Duraisingh, M.T., Roper, C., Walliker, D., Warhurst, D.C., 2000a. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1gene of Plasmodium falciparum. Mol. Microbiol. 36, 955-961. (Pubitemid 30326539)
7. Duraisingh, M.T., Jones, P., Sambou, I., von Seidlein, L., Pinder, M., Warhurst, D.C., 2000b. The tyrosine-86 allele of the pfmdr1gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 108, 13-23. (Pubitemid 30236312)
8. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Ursos, L.M.B., Sidhu, A.B.S., Naude, B., Deitsch, K.W., Su, X.Z., Wootton, J.C., Roepe, P.D., Wellems, T.E., 2000. Mutations in the P. falciparumdigestive vacuole transmembrane protein PFCRT and evidence for their role in chloroquine resistance. Mol. Cell. 6, 861-671.
9. Figueiredo, P., Benchimo, C., Lopes, D., Bernardino, L., E do Rosário, V. Varanda, L., Nogueira, F., 2008. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malaria J. 7, 236
10. Foote, S.J., Thompson, J.K., Cowman, A.F., Kemp, D.J., 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell. 57, 921-930. (Pubitemid 19168372)
11. Hastings, M.D., Bates, S.J., Blackstone, E.A., Monks, S.M., Mutabingwa, T.K., Sibley, C.H., 2002. Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparumfrom Tanzania. Trans. R. Soc. Trop. Med. Hyg. 96, 674-676. (Pubitemid 36231495)
12. Hatabu, T., Iwagami, M., Kawazu, S,I., Taguchi, N., Escueta, A.D., Villacorte, E.A., Rivera, P.T., Kano S., 2009. Association of molecular markers in Plasmodium falciparum crt and mdr1 with in vitro chloroquine resistance: A Philippine study. Parasitol. Int. 58, 166-170.
13. Iriemenam, N.C., Okafor, C.M., Balogun, H.A., Ayede, I., Omosun, Y., Persson, J.O., Hagstedt, M., Anumudu, CI., Nwuba, R.I., Troye-Blomberg, M., Berzins, K., 2009. Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. Afr. Health. Sci. 9, 66-74.
14. Khalil, I., Ronn, A.M., Alifrangis, M, Gabar, H.A., Satti, G.M., Bygbjerg, I.C., 2003. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am. J. Trop. Med. Hyg. 68, 586-589. (Pubitemid 38240499)
15. Kim, N., Bouchier, C., Ekala, M.T., Mercereau-Puijalon O, Fandeur T., 2004. Polymorphisme et chimiorésistance de Plasmodium falciparum au Cambodge. Med. Mal. Infect. 34, S61-S64. (Pubitemid 39078078)
16. Kublin, J.G., Cortese, J.F., Njunju, E.M., Mukadam, R.A., Wirima, J.J., Kazembe, P.N., Djimdé, A.A., Kouriba, B., Taylor T.E., Plowe, C.V., 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187, 1870-1875. (Pubitemid 36724485)
17. Levine, D., 1988. Progress in taxonomy of the Apicomplexan protozoa. J. Protozool. 35, 518-520.
18. Malvy, D., Djossou, F., Receveur, M.C., Le Bras, M., 2000. Plasmodies in: Traitement, prévention. Encyclopédie médico-chirugical (Paris) Elsevier. 8, 507-525.
19. Mberu, E.K., Nzila, A.M., Nduati, E., Ross, A, Monks, S.M., Kokwaro, G.O., Watkins, W.M., Sibley, C.H., 2002. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance. Exp. Parasitol. 101, 90-96. (Pubitemid 36269059)
20. Ndounga, M., Basco, L.K., Ringwald, P., 1999. Variabilité de l'activité in vitro du proguanil et du cycloguanil sur les stades érythrocytaires de Plasmodium falciparumen fonction des conditions de culture. Bull. Soc. Pathol. Exot. 92, 313-316.
21. Ndounga, M., Basco, L.K., Ringwald, P., 2001. Evaluation of a new sulfadoxine sensitivity assay in vitrofor field isolates of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 95: 55-57. (Pubitemid 34202226)
22. Ochong, E., Nzila, A., Kimani, S., Kokwaro, G., Mutabingwa, T., Watkins, W., Marsh, K., 2003. Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa. Malaria J. 2, 46.
23. Peterson, D.S., Milhous, W.K., Wellems, T.E., 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA. 87, 3018-3022.
24. Pillai, D.R., Hijar, G., Montoya, Y., Marouino, W., Ruebush, T.K., 2nd, Wongsrichanalai, C., Kain, K.C., 2003. Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru. Am. J. Trop. Med. Hyg. 68, 107-110. (Pubitemid 38234857)
25. Reed, M.B, Saliba, K.J, Caruana, S.R, Kirk, K, Cowman, A.F, 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403, 906-909. (Pubitemid 30130994)
26. Tinto, H., Ouedraogo, J.B., Erhart, A., Van Overmeir, C., Dujardin, J.C, Van Marck, E., Guiguemde, T.R., D'Alessandro, U., 2003. Relationship between the PfcrtT76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparumand in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect. Genet. Evol. 3, 287-292. (Pubitemid 37408279)
27. Triglia, T., Menting, J.G.T., Wilson, C., Cowman, A.F., 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 94, 13944-13949. (Pubitemid 28009689)
28. Van den Broek, IV., van der Wardt, S., Talukder, L., Chakma, S., Brockman, A., Nair, S., Anderson, T.C., 2004. Drug resistance in Plasmodium falciparumfrom the Chittagong Hill Tracts, Bangladesh. Trop. Med. Inter. Health. 9, 680-687. (Pubitemid 38833333)
29. Wang, P., Read, M., Sims, P.F., Hyde, J.E., 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparumis determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23, 979-986. (Pubitemid 27096733)
30. Wellems, T.E and Plowe, C.V., 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184, 770-6. (Pubitemid 32826429)
31. Wichmann, O., Jelinek, T., Peyerl-Hoffmann, G., Mühlberger, N., Grobusch, M.P., Gascon, J., Matteelli, A., Hatz, C., Laferl, H., Schulze, M., Burchard, G., da Cunha, S., Beran, J., McWhinney, P., Kollaritsch, H., Kern, P., Cuadros, J., Alifrangis, M., Gjørup, I., 2003. Molecular surveillance of the antifolate-resistant mutation I164L in imported African isolates of Plasmodium falciparum in Europe: sentinel data from TropNetEurop. Malaria J. 2, 17.
32. World Health Organization.,1990. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop. Med. Hyg. 84 (Suppl 2), 1-65.
33. World Health Organization., 2008. World malaria report WHO/HTM/GMP, 2008.1. 190p.